Medicare Enrolled
Dr. Silvia Romero, M.D.
Internal Medicine · Fort Myers, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Romero from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Romero? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Romero
Dr. Silvia Romero is an internal medicine in Fort Myers, FL, with 20 years in practice. Based on federal Medicare data, Dr. Romero performed 144,750 Medicare services across 4,312 unique beneficiaries.
Between the years covered by Open Payments, Dr. Romero received a total of $6,430 from 51 pharmaceutical and/or device companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Romero is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 0% volume in FL$ $6,430 industry payments
Medicare Practice Summary
Medicare Utilization ↗144,750
Medicare services
Top 0% in FL for internal medicine
4,312
Unique beneficiaries
$14
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,238 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Pembrolizumab injection (Keytruda) | 22,400 | $43 | $137 |
| Filgrastim injection (Zarxio) for white blood cells | 16,440 | $0 | $2 |
| Anti-nausea injection (aprepitant) | 15,210 | $1 | $5 |
| Iron infusion (Feraheme) | 13,260 | $0 | $4 |
| Denosumab injection (Prolia/Xgeva) | 8,700 | $18 | $51 |
| Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 8,700 | $1 | $3 |
| Epoetin alfa injection (Procrit) for anemia | 7,980 | $6 | $23 |
| Paclitaxel chemotherapy injection | 7,828 | $0 | $2 |
| Daratumumab injection (Darzalex) | 7,380 | $37 | $110 |
| Azacitidine chemotherapy injection | 6,800 | $0 | $4 |
| Iron sucrose injection (Venofer) | 5,500 | $0 | $5 |
| Immune globulin infusion (Gammagard) | 2,970 | $36 | $108 |
| Dexamethasone injection (steroid) | 2,501 | $0 | $3 |
| Injection, eflapegrastim-xnst, 0.1 mg | 2,244 | $26 | $116 |
| Complete blood count (CBC) with differential | 2,090 | $8 | $29 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,960 | $1 | $28 |
| Blood draw (venipuncture) | 1,625 | $8 | $9 |
| Injection, fulvestrant, 25 mg | 1,420 | $8 | $132 |
| Injection, leucovorin calcium, per 50 mg | 1,002 | $3 | $12 |
| Office visit, established patient (30-39 min) | 952 | $99 | $339 |
| Anti-nausea injection (ondansetron/Zofran) | 772 | $0 | $9 |
| Injection, fluorouracil, 500 mg | 687 | $2 | $7 |
| Drug injection, under skin or into muscle | 671 | $11 | $69 |
| Injection of additional new drug or substance into vein | 660 | $12 | $61 |
| Office visit, established patient (20-29 min) | 537 | $66 | $239 |
| Administration of chemotherapy into vein, 1 hour or less | 528 | $104 | $378 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 457 | $3 | $205 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 432 | $84 | $642 |
| Injection, carboplatin, 50 mg | 400 | $2 | $41 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 203 | $49 | $189 |
| Injection, diphenhydramine hcl, up to 50 mg | 173 | $1 | $3 |
| Administration of chemotherapy into vein, each additional hour | 168 | $23 | $79 |
| Administration of additional new drug or substance into vein, 1 hour or less | 164 | $52 | $178 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 162 | $23 | $84 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 157 | $1 | $6 |
| Injection, zoledronic acid, 1 mg | 143 | $6 | $69 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 140 | $26 | $89 |
| Infusion into a vein for hydration, each additional hour | 132 | $10 | $42 |
| Infusion, normal saline solution , 1000 cc | 119 | $2 | $7 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 112 | $17 | $59 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 103 | $57 | $206 |
| Administration of additional new drug or substance into vein using push technique | 87 | $45 | $170 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 83 | $134 | $637 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 81 | $16 | $56 |
| Infusion into a vein for hydration, 31-60 minutes | 78 | $26 | $156 |
| Automated urinalysis | 77 | $2 | $8 |
| Injection, magnesium sulfate, per 500 mg | 76 | $1 | $2 |
| New patient office visit, complex (60-74 min) | 61 | $176 | $585 |
| Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion | 59 | $16 | $56 |
| Injection of drug or substance into vein | 50 | $29 | $156 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 41 | $3 | $11 |
| Red blood count automated, with additional calculations | 37 | $5 | $20 |
| Application of on-body injector for under skin injection | 35 | $15 | $56 |
| Administration of chemotherapy into vein using push technique | 28 | $81 | $303 |
| Office visit, established patient, complex (40-54 min) | 22 | $139 | $474 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 21 | $1 | $7 |
| New patient office visit (45-59 min) | 19 | $123 | $453 |
| Red blood count, automated test | 13 | $4 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.9% high complexity
84.1% medium
4.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,430
Total received (2018-2024)
Avg $919/year across 7 years
Top 11% in FL for internal medicine
51
Companies
344
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,430 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,508
2023$833
2022$1,013
2021$513
2020$722
2019$933
2018$906
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$999
E.R. Squibb & Sons, L.L.C.
$876
Merck Sharp & Dohme Corporation
$324
PFIZER INC.
$263
Celgene Corporation
$263
Gilead Sciences, Inc.
$210
BeiGene USA, Inc.
$207
Teva Pharmaceuticals USA, Inc.
$192
Seagen Inc.
$188
TAIHO ONCOLOGY, INC.
$185
Veracyte, Inc.
$172
Daiichi Sankyo Inc.
$166
Bayer HealthCare Pharmaceuticals Inc.
$160
AstraZeneca Pharmaceuticals LP
$155
Incyte Corporation
$148
Genentech USA, Inc.
$144
Novartis Pharmaceuticals Corporation
$139
Astellas Pharma US Inc
$129
Takeda Pharmaceuticals U.S.A., Inc.
$121
NanoString Technologies, Inc.
$114
Janssen Pharmaceuticals, Inc
$110
JAZZ PHARMACEUTICALS INC.
$109
Lilly USA, LLC
$94
Mirati Therapeutics, Inc.
$94
Amgen Inc.
$74
ARRAY BIOPHARMA INC
$71
Exelixis Inc.
$70
Regeneron Healthcare Solutions, Inc.
$63
ABBVIE INC.
$62
Merck Sharp & Dohme LLC
$60
EMD Serono, Inc.
$57
GENZYME CORPORATION
$48
GE HEALTHCARE
$40
CSL Behring
$38
Eisai Inc.
$37
Pharmacyclics LLC, An AbbVie Company
$25
PUMA BIOTECHNOLOGY, INC.
$20
TerSera Therapeutics LLC
$20
AbbVie, Inc.
$20
GlaxoSmithKline, LLC.
$20
Taiho Oncology, Inc.
$18
SANOFI-AVENTIS U.S. LLC
$18
Array BioPharma Inc.
$16
ADC Therapeutics America, Inc.
$15
Sumitomo Pharma America, Inc.
$14
Dendreon Pharmaceuticals LLC
$14
Puma Biotechnology, Inc.
$13
Sirtex Medical Inc
$12
AbbVie Inc.
$12
Clovis Oncology, Inc.
$5
Heron Therapeutics, Inc.
$4
Top 3 companies account for 34.2% of total payments
Associated products mentioned in payments ›
Abraxane · Alecensa · Aliqopa · BLENREP · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · Cabometyx · Cinvanti · DARZALEX · ELAHERE · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Erleada · FRUZAQLA · GAZYVA · HYQVIA · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INLYTA · Idelvion · JAKAFI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MONJUVI · NERLYNX · NINLARO · ONUREG · OPDIVO · ORGOVYX · PADCEV · PLUVICTO · PROSIGNA ASSAY · PROVENGE · Phesgo · Polivy · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · Rubraca · SARCLISA · SIR-Spheres Microspheres · SPRYCEL · Stivarga · TAGRISSO · TECVAYLI · TIVDAK · TUKYSA · Tecentriq · Trodelvy · VENCLEXTA · VERZENIO · VYXEOS · Venclexta · Vyloy · XARELTO · XTANDI · Xospata · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $4 per 100 Medicare services performed
Geographic Context
Internal Medicines within 10 mi
382
Per 100K population
48.2
County median income
$73,099
Nearest hospital
LEE MEMORIAL HOSPITAL
8.0 mi
8.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Romero is a mixed practice specialist, with above-average Medicare volume (top 0% in FL), and high industry engagement (low-engagement, top 11%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Romero experienced with pembrolizumab injection (keytruda)?
Based on Medicare claims data, Dr. Romero performed 22,400 pembrolizumab injection (keytruda) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Romero receive payments from pharmaceutical companies?
Yes. Dr. Romero received a total of $6,430 from 51 companies across 344 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Romero's costs compare to other internal medicines in Fort Myers?
Dr. Romero's average Medicare payment per service is $14. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Romero) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicines in Fort Myers
Browse internal medicines in Fort Myers ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicines in FL
Internal Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicines in FL
Which FL internal medicines receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc..
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C..
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology